The mechanism of action of the immunosuppressive drug FK-506 - PubMed (original) (raw)
The mechanism of action of the immunosuppressive drug FK-506
J E Kay et al. Cell Immunol. 1989 Nov.
Abstract
The novel immunosuppressive drug FK-506 inhibits the induction of lymphocyte proliferation in vitro by mitogenic combinations of phorbol esters and calcium ionophores. Early events inducible by phorbol esters alone are unaffected, while changes induced by calcium ionophores alone are completely suppressed by as little as 0.1 nM FK-506. The event in lymphocyte activation inhibited by FK-506 is completed early in the response. Its completion requires the provision of a Ca2+ signal and concurrent activation of protein kinase C and is accelerated as a function of the strength of protein kinase C activation.
Similar articles
- Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.
Zeevi A, Eiras G, Bach FH, Fung JJ, Todo S, Starzl T, Duquesnoy RJ. Zeevi A, et al. Transplant Proc. 1990 Feb;22(1):106-9. Transplant Proc. 1990. PMID: 1689884 Free PMC article. No abstract available. - FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
Lin CS, Boltz RC, Siekierka JJ, Sigal NH. Lin CS, et al. Cell Immunol. 1991 Apr 1;133(2):269-84. doi: 10.1016/0008-8749(91)90103-i. Cell Immunol. 1991. PMID: 1707760 - Observations on the mechanism of action of FK-506. A pharmacologic probe of lymphocyte signal transduction.
Sigal NH, Siekierka JJ, Dumont FJ. Sigal NH, et al. Biochem Pharmacol. 1990 Nov 15;40(10):2201-8. doi: 10.1016/0006-2952(90)90712-t. Biochem Pharmacol. 1990. PMID: 1700909 Review. No abstract available. - FK 506: an immunosuppressant for the 1990s?
Macleod AM, Thomson AW. Macleod AM, et al. Lancet. 1991 Jan 5;337(8732):25-7. doi: 10.1016/0140-6736(91)93341-6. Lancet. 1991. PMID: 1702172 Review.
Cited by
- A Review of Calcineurin Biophysics with Implications for Cardiac Physiology.
Williams RB, Johnson CN. Williams RB, et al. Int J Mol Sci. 2021 Oct 26;22(21):11565. doi: 10.3390/ijms222111565. Int J Mol Sci. 2021. PMID: 34768996 Free PMC article. Review. - Variation in PPP3CC Genotype Is Associated with Long-Term Recovery after Severe Brain Injury.
Osier ND, Bales JW, Pugh B, Shin S, Wyrobek J, Puccio AM, Okonkwo DO, Ren D, Alexander S, Conley YP, Dixon CE. Osier ND, et al. J Neurotrauma. 2017 Jan 1;34(1):86-96. doi: 10.1089/neu.2015.4343. Epub 2016 Jun 27. J Neurotrauma. 2017. PMID: 27225880 Free PMC article. - Mechanisms of dendritic spine remodeling in a rat model of traumatic brain injury.
Campbell JN, Low B, Kurz JE, Patel SS, Young MT, Churn SB. Campbell JN, et al. J Neurotrauma. 2012 Jan 20;29(2):218-34. doi: 10.1089/neu.2011.1762. Epub 2011 Sep 29. J Neurotrauma. 2012. PMID: 21838518 Free PMC article. - Regional calcineurin subunit B isoform expression in rat hippocampus following a traumatic brain injury.
Bales JW, Ma X, Yan HQ, Jenkins LW, Dixon CE. Bales JW, et al. Brain Res. 2010 Oct 28;1358:211-20. doi: 10.1016/j.brainres.2010.08.029. Epub 2010 Aug 13. Brain Res. 2010. PMID: 20713027 Free PMC article. - The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.
Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ. Randhawa PS, et al. Am J Surg Pathol. 1993 Jan;17(1):60-8. doi: 10.1097/00000478-199301000-00007. Am J Surg Pathol. 1993. PMID: 7680544 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous